Gabanan, Dan B.

HRN: 25-85-73  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2024
CO-AMOXICLAV 625MG (TAB)
09/15/2024
09/22/2024
PER OREM
1tab
BID
UTI Complicated
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: